# EDGAR Filing Document

**Accession Number:** 0001499785
**File Stem:** 0001213900-23-025474
**Filing Date:** 2023-3
**Character Count:** 5844
**Document Hash:** 1077539d2a5970146c076553f13be795
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-23-025474.hdr.sgml**: 20230331

**ACCESSION NUMBER**: 0001213900-23-025474

**CONFORMED SUBMISSION TYPE**: NT 10-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230331

**DATE AS OF CHANGE**: 20230331

**EFFECTIVENESS DATE**: 20230331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Tengjun Biotechnology Corp.
- **CENTRAL INDEX KEY:** 0001499785
- **STANDARD INDUSTRIAL CLASSIFICATION:** BEVERAGES [2080]
- **IRS NUMBER:** 273042462
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NT 10-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 333-169397
- **FILM NUMBER:** 23787793

**BUSINESS ADDRESS:**
- **STREET 1:** FOOD INDUSTRY ECONOMIC AND TECHNOLOGY
- **STREET 2:** DEVELOPMENT DISTRICT
- **CITY:** JINING, SHANDONG
- **STATE:** F4
- **ZIP:** 214028
- **BUSINESS PHONE:** 8613909840703

**MAIL ADDRESS:**
- **STREET 1:** FOOD INDUSTRY ECONOMIC AND TECHNOLOGY
- **STREET 2:** DEVELOPMENT DISTRICT
- **CITY:** JINING, SHANDONG
- **STATE:** F4
- **ZIP:** 214028

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** China Herb Group Holdings Corp
- **DATE OF NAME CHANGE:** 20120717

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Island Radio, Inc.
- **DATE OF NAME CHANGE:** 20100823

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, DC 20549**

**FORM 12b-25**

SEC File Number: 333-169397

NOTIFICATION OF LATE FILING

(Check one) ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR

For period ended <u>December 31, 2022</u>

☐ Transition Report on Form 10-K

☐ Transition Report on Form 20-F

☐ Transition Report on Form 11-K

☐ Transition Report on Form 10-Q

☐ Transition Report on Form N-SAR

For the transition period ended ___________________________

**Nothing in this form shall be construed to imply that the Commission<br> has verified any information contained herein.**

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

**PART I**

**REGISTRANT INFORMATION**

Full Name of Registrant <u>Tengjun Biotechnology Corp.</u>

Former Name if Applicable <u>China Herb Group Holdings Corporation</u>

Address of Principal Executive Office (*Street and Number*) <u>East Jinze Road and South Huimin Road, Food Industry Economic and Technology Development District, Jinxiang County</u>

City, State and Zip Code <u>Jining City, Shandong Province, China</u> 

**PART II**

**RULES 12b-25(b) AND (c)**

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)

(a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

☒ (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11–K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on of before the fifth calendar day following the prescribed due date; and

(c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

**PART III**

**NARRATIVE**

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

Tengjun Biotechnology Corp. (the "Company") filed a Form 8-K on March 24, 2023 to report the discontinuance of its previous independent registered public accountant and the appointment of a new independent registered public accountant, PWN LLP. The audit of the Company's financial statements for the year ended December 31, 2022 commenced shortly after the appointment of PWN LLP, but there has been insufficient time for PWN LLP to complete its audit of the Company's consolidated financial statements of 2022 in order for the Company to file its Annual Report on Form 10-K for the year ended December 31, 2022 within the prescribed time period without incurring unreasonable effort and expense. The Company does, however, expect to file such report within fifteen calendar days thereof.

**PART IV**

**OTHER INFORMATION**

(1) Name and telephone number of person to contact in regard to
this notification.

<u>Xianchang Ma</u> <u>86</u> <u>0537-8711599</u> <br> (Name) (Area Code) (Telephone Number)

(2) Have all other periodic reports required under Section 13 or
15(d) or the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for
such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). ☒ Yes ☐ No

(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the
subject report or portion thereof? ☐ Yes ☒ No

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

<u>Tengjun Biotechnology Corp.</u>

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Date: March 31, 2023 | By: | */s/ Xianchang Ma* |
|  | Name: | Xianchang Ma |
|  | Title: | Chief Executive Officer |

---